Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600

Rhea-AI Summary

Crocs Inc. (CROX) is set to replace Cantel Medical Corp. (CMD) in the S&P MidCap 400, effective June 2, 2021. Concurrently, Organogenesis Holdings Inc. (ORGO) will take Crocs' place in the S&P SmallCap 600. This change is part of an acquisition by STERIS plc of Cantel Medical, which is anticipated to conclude soon pending final conditions. This move reflects Crocs' growing presence in the market and the dynamics of index composition.

Positive

• Crocs is moving up to the S&P MidCap 400, indicating stronger market perception.
• The change may increase institutional investor interest due to Crocs' new index position.

Negative

• Crocs will be deleted from the S&P SmallCap 600, which may impact its visibility among smaller-cap investors.

NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, June 2, 2021. STERIS plc (NYSE: STE) is acquiring Cantel Medical in a deal expected to be completed soon pending final closing conditions.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date	Index Name	Action	Company Name	Ticker	GICS Sector
June 2, 2021	S&P MidCap 400	Addition	Crocs	CROX	Consumer Discretionary
	S&P MidCap 400	Deletion	Cantel Medical	CMD	Health Care
	S&P SmallCap 600	Addition	Organogenesis Holdings	ORGO	Health Care
	S&P SmallCap 600	Deletion	Crocs	CROX	Consumer Discretionary

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
index_services@spglobal.com

Media Inquiries
spdji.comms@spglobal.com

View original content:http://www.prnewswire.com/news-releases/crocs-set-to-join-sp-midcap-400-and-organogenesis-to-join-sp-smallcap-600-301300374.html

SOURCE S&P Dow Jones Indices

FAQ

When will Crocs join the S&P MidCap 400?

Crocs will join the S&P MidCap 400 effective June 2, 2021.

What company is replacing Crocs in the S&P SmallCap 600?

Organogenesis Holdings Inc. (ORGO) will replace Crocs in the S&P SmallCap 600.

What is the significance of Crocs moving to the S&P MidCap 400?

This move reflects Crocs' growing market presence and could enhance institutional investor interest.

What happened to Cantel Medical Corp. (CMD)?

Cantel Medical Corp. is being acquired by STERIS plc and will be removed from the S&P MidCap 400.